SAN FRANCISCO (GenomeWeb) – The Children's Hospital of Los Angeles plans to begin offering a next-generation sequencing panel at the end of the month as a laboratory-developed test specifically tailored toward pediatric cancers.

Timothy Triche, co-director of the Center for Personalized Medicine at CHLA, said in a presentation at the recent Global AMP conference in Berlin and in a subsequent interview that the group could not simply modify available panels for adult cancers because the genomic alterations seen in pediatric cancers are so different.